A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic

Urologic Oncology: Seminars and Original Investigations

Volumn 34, Issue 5, 2016, Pages 233.e17-233.e25

  Hurwitz, Lauren M ^a,b   Cullen, Jennifer ^a,b,c   Elsamanoudi, Sally ^a,b,d   Kim, Daniel J ^d   Hudak, Jane ^d   Colston, Maryellen ^d   Travis, Judith ^d   Kuo, Huai Ching ^a,b   Porter, Christopher R ^a,e   Rosner, Inger L ^a,d  

^a Center for Prostate Disease Research   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Decision making; Multidisciplinary clinic; Patient preferences; Prostate cancer; Treatment

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER EPIDEMIOLOGY; CANCER SURGERY; CANCER THERAPY; COHORT ANALYSIS; COMORBIDITY; EDUCATIONAL STATUS; HORMONAL THERAPY; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PATIENT PREFERENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RACE DIFFERENCE; AGED; DECISION MAKING; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; PUBLIC HOSPITAL; QUESTIONNAIRE;

AGED; DECISION MAKING; HOSPITALS, MILITARY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT CARE TEAM; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SURVEYS AND QUESTIONNAIRES;

EID: 84950236601     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.11.014     Document Type: Article

References (33)

1. Society A.C. Cancer Facts & Figures 2015. Atlanta: American Cancer Society 2015.
2. Dall'Era M.A., Albertsen P.C., Bangma C., Carroll P.R., Carter H.B., Cooperberg M.R., et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012, 62:976-983. http://dx.doi.org/10.1016/j.eururo.2012.05.072:[Epub Jun 7].
3. Ritch C.R., Graves A.J., Keegan K.A., Ni S., Bassett J.C., Chang S.S., et al. Increasing use of observation among men at low risk for prostate cancer mortality. J Urol 2015, 193:801-806.
4. Sun F, Oyesanmi O, Fontanarosa J, Reston J, Guzzo T, Schoelles K. Therapies for clinically localized prostate cancer: update of a 2008 systematic review. AHRQ Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
5. Zeliadt S.B., Ramsey S.D., Penson D.F., Hall I.J., Ekwueme D.U., Stroud L., et al. Why do men choose one treatment over another? a review of patient decision making for localized prostate cancer. Cancer 2006, 106:1865-1874.
6. Sommers B.D., Beard C.J., D'Amico A.V., Kaplan I., Richie J.P., Zeckhauser R.J. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer 2008, 113:2058-2067. http://dx.doi.org/10.1002/cncr.23807.
7. Ihrig A., Keller M., Hartmann M., Debus J., Pfitzenmaier J., Hadaschik B., et al. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy. BJU Int 2011, 108:1274-1278. http://dx.doi.org/10.111/j.464-410X.2011.10082.x:[Epub 2011 Mar 16].
8. Sidana A., Hernandez D.J., Feng Z., Partin A.W., Trock B.J., Saha S., et al. Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate 2012, 72:58-64. http://dx.doi.org/10.1002/pros.21406:[Epub 2011 Apr 25].
9. Daskivich T.J., Lai J., Dick A.W., Setodji C.M., Hanley J.M., Litwin M.S., et al. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer 2014, 17:28926.
10. Davison B.J., Breckon E.N. Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer. Cancer Nurs 2012, 35:411-418. http://dx.doi.org/10.1097/NCC.0b013e318236565a.
11. Song L., Chen R.C., Bensen J.T., Knafl G.J., Nielsen M.E., Farnan L., et al. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Cancer 2013, 119:421-428. http://dx.doi.org/10.1002/cncr.27738:[Epub 2012 Jul 11].
12. Adsul P., Wray R., Spradling K., Darwish O., Weaver N., Siddiqui S. Systematic review of decision aids for newly diagnosed prostate cancer patients making treatment decisions. J Urol 2015, 5. [04115-4].
13. Violette P.D., Agoritsas T., Alexander P., Riikonen J., Santti H., Agarwal A., et al. Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin 2015, 65:239-251.
14. Wang E.H., Gross C.P., Tilburt J.C., Yu J.B., Nguyen P.L., Smaldone M.C., et al. Shared decision making and use of decision AIDS for localized prostate cancer: perceptions from radiation oncologists and urologists. JAMA Intern Med 2015, 175:792-799. http://dx.doi.org/10.1001/jamainternmed.2015.63.
15. Wagner S.E., Drake B.F., Elder K., Hebert J.R. Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina. Cancer Causes Control 2011, 22:1597-1606. http://dx.doi.org/10.007/s10552-011-9836-2:[Epub 2011 Aug 30].
16. Hudak J.L., McLeod D.G., Brassell S.A., Gant D.A., Shaar S., Hudak R.P., et al. The design and implementation of a multidisciplinary prostate cancer clinic. Urol Nurs 2007, 27:491-498.
17. Degner L.F., Sloan J.A., Venkatesh P. The control preferences scale. Can J Nurs Res 1997, 29:21-43.
18. Holmes-Rovner M., Kroll J., Schmitt N., Rovner D.R., Breer M.L., Rothert M.L., et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996, 16:58-64.
19. Brehaut J.C., O'Connor A.M., Wood T.J., Hack T.F., Siminoff L., Gordon E., et al. Validation of a decision regret scale. Med Decis Making 2003, 23:281-292.
20. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., Sanda M.G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56:899-905.
21. Ware J.E.J. SF-36 health survey update. Spine 2000, 25:3130-3139.
22. Brazier J.E., Harper R., Jones N.M., O'Cathain A., Thomas K.J., Usherwood T., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992, 305:160-164.
23. Aizer A.A., Paly J.J., Efstathiou J.A. Multidisciplinary care and management selection in prostate cancer. Semin Radiat Oncol 2013, 23:157-164.
24. Aizer A.A., Paly J.J., Zietman A.L., Nguyen P.L., Beard C.J., Rao S.K., et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol 2012, 30:3072-3076.
25. Korman H., Lanni T., Shah C., Parslow J., Tull J., Ghilezan M., et al. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Am J Clin Oncol 2013, 36:121-125. http://dx.doi.org/10.1097/COC.0b013e318243708f.
26. Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010, 28:1117-1123. http://dx.doi.org/10.200/JCO.2009.26.0133:[Epub 2010 Feb 1].
27. Moses K.A., Paciorek A.T., Penson D.F., Carroll P.R., Master V.A. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol 2010, 28:1069-1074. http://dx.doi.org/10.200/JCO.2009.26.469:[Epub 10 Jan 25].
28. Hosain G.M., Sanderson M., Du X.L., Chan W., Strom S.S. Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. Am J Mens Health 2012, 6:249-257.
29. Mahal B.A., Ziehr D.R., Aizer A.A., Hyatt A.S., Lago-Hernandez C., Choueiri T.K., et al. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer. J Geriatr Oncol 2014, 5:352-358.
30. Mahal B.A., Ziehr D.R., Aizer A.A., Hyatt A.S., Sammon J.D., Schmid M., et al. Getting back to equal: the influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urol Oncol 2014, 32:1285-1291. http://dx.doi.org/10.016/j.urolonc.2014.04.014:[Epub May 17].
31. Bureau USC. Current Population Survey, 2014. Annual Social and Economic Supplement. 2014.
32. Weiner A.B., Patel S.G., Etzioni R., Eggener S.E. National trends in the management of low and intermediate risk prostate cancer in the United States. J Urol 2015, 193:95-102. 10.1016/j.juro.2014.07.11110.1016/j.juro.2014.07.111:[Epub Aug 5].
33. Filson C.P., Schroeck F.R., Ye Z., Wei J.T., Hollenbeck B.K., Miller D.C. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. J Urol 2014, 8:230-234.